Table 1. Patient demographic and clinical details.

Patient	Age	Gender	Duration of	Parkinsonian symptoms		Autonomic	Cerebellar	Babinski sign	MRI singal change or atrophy			Medication
			symptoms	UPDRS (part 3)		failure	dysfucntion	with hyperreflexia	Putamen	Brainstem	Cerebellum
	(years)		(years)	On	Off							(mg/day)
PD1	63	F	2	3	10	-	-	-	-	-	-	100
PD2	61	F	3	4	14	-	-	-	-	-	-	200
PD3	67	M	2	8	14	-	-	-	-	-	-	100
PD4	68	F	3	6	28	-	-	-	-	-	-	300
PD5	65	F	3	5	17	-	-	-	-	-	-	250
PD6	58	M	4	18	35	+	-	-	-	-	-	300
PD7	75	F	2	6	14	-	-	-	-	-	-	200
PD8	62	M	3	5	11	-	-	-	-	-	-	300
PD9	57	F	3	13	29	-	-	-	-	-	-	250
PD10	62	M	2	10	12	+	-	-	-	-	-	300
MSA1	54	F	3	29	29	+	-	-	+	+	+	300
MSA2	68	F	3	39	39	+	-	-	+	-	-	300
MSA3	42	M	2	7	19	-	-	-	-	-	-	100
MSA4	48	F	2	15	17	+	-	-	+	-	-	300
MSA5	68	M	2	11	13	+	-	-	+	-	-	300
MSA6	75	F	3	13	13	+	-	-	+	+	+	200
MSA7	64	M	3	28	31	+	-	-	+	+	+	300
MSA8	42	F	2	32	34	+	+	-	+	+	+	200
MSA9	76	F	5	34	38	+	+	-	+	+	+	300
MSA10	62	M	2	11	12	+	-	-	+	-	-	300